HEADER VIRAL PROTEIN/INHIBITOR 21-SEP-17 6B3H
TITLE CRYSTAL STRUCTURE OF HIV PROTEASE COMPLEXED WITH N-(2-(2-((6R,9S)-2,2-
TITLE 2 DIOXIDO-2-THIA-1,7-DIAZABICYCLO[4.3.1]DECAN-9-YL)ETHYL)-3-
TITLE 3 FLUOROPHENYL)-3,3-BIS(4-FLUOROPHENYL)PROPANAMIDE
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: HIV-1 PROTEASE;
COMPND 3 CHAIN: A, B;
COMPND 4 EC: 3.4.23.16;
COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1;
SOURCE 3 ORGANISM_COMMON: HIV-1;
SOURCE 4 ORGANISM_TAXID: 11676;
SOURCE 5 GENE: GAG-POL;
SOURCE 6 EXPRESSION_SYSTEM: HUMAN IMMUNODEFICIENCY VIRUS 1;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 11676
KEYWDS HIV, PROTEASE, VIRAL PROTEIN, VIRAL PROTEIN-INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR H.P.SU
REVDAT 2 13-MAR-24 6B3H 1 REMARK
REVDAT 1 03-JAN-18 6B3H 0
JRNL AUTH C.J.BUNGARD,P.D.WILLIAMS,J.SCHULZ,C.M.WISCOUNT,M.K.HOLLOWAY,
JRNL AUTH 2 H.M.LOUGHRAN,J.J.MANIKOWSKI,H.P.SU,D.J.BENNETT,L.CHANG,
JRNL AUTH 3 X.J.CHU,A.CRESPO,M.P.DWYER,K.KEERTIKAR,G.J.MORRIELLO,
JRNL AUTH 4 A.W.STAMFORD,S.T.WADDELL,B.ZHONG,B.HU,T.JI,T.L.DIAMOND,
JRNL AUTH 5 C.BAHNCK-TEETS,S.S.CARROLL,J.F.FAY,X.MIN,W.MORRIS,
JRNL AUTH 6 J.E.BALLARD,M.D.MILLER,J.A.MCCAULEY
JRNL TITL DESIGN AND SYNTHESIS OF PIPERAZINE SULFONAMIDE CORES LEADING
JRNL TITL 2 TO HIGHLY POTENT HIV-1 PROTEASE INHIBITORS.
JRNL REF ACS MED CHEM LETT V. 8 1292 2017
JRNL REFN ISSN 1948-5875
JRNL PMID 29259750
JRNL DOI 10.1021/ACSMEDCHEMLETT.7B00386
REMARK 2
REMARK 2 RESOLUTION. 1.62 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER 2.11.7
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.62
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.91
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 92.7
REMARK 3 NUMBER OF REFLECTIONS : 28148
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.178
REMARK 3 R VALUE (WORKING SET) : 0.177
REMARK 3 FREE R VALUE : 0.199
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.040
REMARK 3 FREE R VALUE TEST SET COUNT : 1418
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 14
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.62
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.68
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 61.09
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 1906
REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2272
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1818
REMARK 3 BIN R VALUE (WORKING SET) : 0.2262
REMARK 3 BIN FREE R VALUE : 0.2490
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.62
REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 1510
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 84
REMARK 3 SOLVENT ATOMS : 158
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 23.31
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.05
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -1.26160
REMARK 3 B22 (A**2) : 5.05860
REMARK 3 B33 (A**2) : -3.79710
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.200
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.088
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.085
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.084
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.082
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.953
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 1624 ; 2.000 ; HARMONIC
REMARK 3 BOND ANGLES : 2207 ; 2.000 ; HARMONIC
REMARK 3 TORSION ANGLES : 583 ; 2.000 ; SINUSOIDAL
REMARK 3 TRIGONAL CARBON PLANES : 34 ; 8.000 ; HARMONIC
REMARK 3 GENERAL PLANES : 269 ; 8.000 ; HARMONIC
REMARK 3 ISOTROPIC THERMAL FACTORS : 1624 ; 20.000 ; HARMONIC
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 218 ; 5.000 ; SEMIHARMONIC
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 1979 ; 4.000 ; SEMIHARMONIC
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.010
REMARK 3 BOND ANGLES (DEGREES) : 1.09
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.81
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.62
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 6B3H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-SEP-17.
REMARK 100 THE DEPOSITION ID IS D_1000230181.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 15-MAR-17
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 17-ID
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : AIMLESS
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 166669
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.616
REMARK 200 RESOLUTION RANGE LOW (A) : 19.910
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 92.6
REMARK 200 DATA REDUNDANCY : 5.900
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 20.5000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS
REMARK 200 SOFTWARE USED: BUSTER
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 54.34
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.69
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM SODIUM ACETATE PH 5.0-5.5 300
REMARK 280 -500 MM NACL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z
REMARK 290 3555 -X+1/2,Y+1/2,-Z
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 29.21500
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.10000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.21500
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.10000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 4680 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 9450 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -59.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 ARG A 41 CG CD NE CZ NH1 NH2
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue CN4 A 101
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 102
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue CN4 B 101
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 102
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 103
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 104
DBREF 6B3H A 1 99 UNP P04587 POL_HV1B5 501 599
DBREF 6B3H B 1 99 UNP P04587 POL_HV1B5 501 599
SEQADV 6B3H LYS A 7 UNP P04587 GLN 507 CONFLICT
SEQADV 6B3H ILE A 33 UNP P04587 LEU 533 CONFLICT
SEQADV 6B3H ILE A 63 UNP P04587 LEU 563 CONFLICT
SEQADV 6B3H LYS B 7 UNP P04587 GLN 507 CONFLICT
SEQADV 6B3H ILE B 33 UNP P04587 LEU 533 CONFLICT
SEQADV 6B3H ILE B 63 UNP P04587 LEU 563 CONFLICT
SEQRES 1 A 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE
SEQRES 2 A 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR
SEQRES 3 A 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO
SEQRES 4 A 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY
SEQRES 5 A 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU
SEQRES 6 A 99 ILE CYS GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY
SEQRES 7 A 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR
SEQRES 8 A 99 GLN ILE GLY CYS THR LEU ASN PHE
SEQRES 1 B 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE
SEQRES 2 B 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR
SEQRES 3 B 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO
SEQRES 4 B 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY
SEQRES 5 B 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU
SEQRES 6 B 99 ILE CYS GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY
SEQRES 7 B 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR
SEQRES 8 B 99 GLN ILE GLY CYS THR LEU ASN PHE
HET CN4 A 101 40
HET CL A 102 1
HET CN4 B 101 40
HET CL B 102 1
HET CL B 103 1
HET CL B 104 1
HETNAM CN4 N-(2-{2-[(6R,9S)-2,2-DIOXO-2LAMBDA~6~-THIA-1,7-
HETNAM 2 CN4 DIAZABICYCLO[4.3.1]DECAN-9-YL]ETHYL}-3-FLUOROPHENYL)-
HETNAM 3 CN4 3,3-BIS(4-FLUOROPHENYL)PROPANAMIDE
HETNAM CL CHLORIDE ION
FORMUL 3 CN4 2(C30 H32 F3 N3 O3 S)
FORMUL 4 CL 4(CL 1-)
FORMUL 9 HOH *158(H2 O)
HELIX 1 AA1 GLY A 86 THR A 91 1 6
HELIX 2 AA2 GLN A 92 GLY A 94 5 3
HELIX 3 AA3 GLY B 86 THR B 91 1 6
SHEET 1 AA1 4 GLN A 2 ILE A 3 0
SHEET 2 AA1 4 THR B 96 ASN B 98 -1 O LEU B 97 N ILE A 3
SHEET 3 AA1 4 THR A 96 ASN A 98 -1 N THR A 96 O ASN B 98
SHEET 4 AA1 4 GLN B 2 ILE B 3 -1 O ILE B 3 N LEU A 97
SHEET 1 AA2 8 LYS A 43 GLY A 49 0
SHEET 2 AA2 8 GLY A 52 ILE A 66 -1 O VAL A 56 N LYS A 45
SHEET 3 AA2 8 HIS A 69 VAL A 77 -1 O ALA A 71 N ILE A 64
SHEET 4 AA2 8 THR A 31 ILE A 33 1 N ILE A 33 O LEU A 76
SHEET 5 AA2 8 ILE A 84 ILE A 85 -1 O ILE A 84 N VAL A 32
SHEET 6 AA2 8 GLN A 18 LEU A 24 1 N LEU A 23 O ILE A 85
SHEET 7 AA2 8 LEU A 10 ILE A 15 -1 N ILE A 13 O LYS A 20
SHEET 8 AA2 8 GLY A 52 ILE A 66 -1 O GLU A 65 N LYS A 14
SHEET 1 AA3 8 LYS B 43 GLY B 49 0
SHEET 2 AA3 8 GLY B 52 ILE B 66 -1 O GLN B 58 N LYS B 43
SHEET 3 AA3 8 HIS B 69 VAL B 77 -1 O HIS B 69 N ILE B 66
SHEET 4 AA3 8 VAL B 32 ILE B 33 1 N ILE B 33 O LEU B 76
SHEET 5 AA3 8 ILE B 84 ILE B 85 -1 O ILE B 84 N VAL B 32
SHEET 6 AA3 8 GLN B 18 LEU B 24 1 N LEU B 23 O ILE B 85
SHEET 7 AA3 8 LEU B 10 ILE B 15 -1 N ILE B 13 O LYS B 20
SHEET 8 AA3 8 GLY B 52 ILE B 66 -1 O GLU B 65 N LYS B 14
SITE 1 AC1 14 TRP A 6 GLY A 27 ASP A 29 ASP A 30
SITE 2 AC1 14 VAL A 32 LYS A 45 ILE A 47 GLY A 48
SITE 3 AC1 14 LEU A 76 HOH A 217 HOH A 221 ARG B 8
SITE 4 AC1 14 VAL B 82 CN4 B 101
SITE 1 AC2 3 THR A 74 ASN A 88 ARG B 41
SITE 1 AC3 20 ARG A 8 LEU A 23 ASP A 25 GLY A 27
SITE 2 AC3 20 GLY A 49 ILE A 50 VAL A 82 CN4 A 101
SITE 3 AC3 20 HOH A 220 ASP B 25 GLY B 27 ALA B 28
SITE 4 AC3 20 ASP B 29 ASP B 30 VAL B 32 GLY B 48
SITE 5 AC3 20 GLY B 49 ILE B 50 ILE B 84 HOH B 231
SITE 1 AC4 4 HOH A 262 THR B 74 ASN B 88 HOH B 226
SITE 1 AC5 1 TRP B 6
SITE 1 AC6 3 VAL B 11 THR B 12 CYS B 67
CRYST1 58.430 86.200 46.230 90.00 90.00 90.00 P 21 21 2 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.017114 0.000000 0.000000 0.00000
SCALE2 0.000000 0.011601 0.000000 0.00000
SCALE3 0.000000 0.000000 0.021631 0.00000